骨髓生成
髓系白血病
生存分析
斑马鱼
肿瘤科
医学
内科学
癌症研究
生物
髓样
基因
造血
干细胞
遗传学
作者
Chang‐Kyu Oh,Mihyang Ha,Myoung‐Eun Han,Hye Jin Heo,Kyungjae Myung,Yoonsung Lee,Sae‐Ock Oh,Yun Hak Kim
摘要
Abstract Accurate prediction of malignancies is important in choosing therapeutic strategies. Although there are many genetic and cytogenetic prognostic factors for acute myeloid leukemia (AML), prognosis is difficult to predict because of the heterogeneity of AML. Prognostic factors, including messenger RNA (mRNA) expression, have been determined for other malignancies, but not for AML. A total of 402 patients from The Cancer Genome Atlas, GSE12417 (GPL96, 97), and GSE12417 (GPL570) were included in this study. In Kaplan‐Meier curve analyses, high expression of family with sequence similarity 213 member A ( FAM213A ), which activates antioxidant proteins, was associated with worse prognosis of AML. Similar to the results of the survival curve, C ‐indices and area under the curve values were high. Current prognostic factors of AML, unlike those of other cancers, do not take mRNA expression into consideration. Thus, the development of mRNA‐based prognostic factors would be beneficial for accurate prediction of the survival of AML patients. Additionally, in vivo validation using zebrafish revealed that fam213a is important for myelopoiesis at the developmental stage and is a negative regulator of the p53 tumor suppressor gene. The findings implicate fam213a as a novel prognostic factor for AML patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI